[Paris, France – 8 April 2022]
We’re proud to announce that Plantibodies has been selected for a strategic coaching program following our pitch at the France Bioproduction Startup Congress 2022, a key event bringing together emerging biotech companies and industrial leaders in biomanufacturing.
Out of a competitive group of startups, Plantibodies was chosen for its innovative platform enabling the production of biologics through plant-based systems. This recognition underscores the relevance of our approach in reshaping how complex biologics — including monoclonal antibodies and therapeutic enzymes — can be manufactured with high precision and lower costs.
The coaching opportunity offers us access to expert mentorship and feedback from leading biomanufacturing professionals, helping us refine our strategy, navigate industrial challenges, and scale our technology for future clinical and commercial use.
“This is a meaningful step forward for us,” says Pierre Bauër, CEO and co-founder. “It’s an early vote of confidence from the biomanufacturing ecosystem, and it accelerates our ability to build a robust, scalable, and sustainable biotech platform.”
We thank the organizers and jury for their support and look forward to the next stage of our journey.